Latest Human leukocyte antigen Stories
ADDISON, Texas, April 20 /PRNewswire/ -- New guidelines to diagnose and treat antibody mediated rejection (AMR) in cardiac transplant patients will be the focus of a consensus conference today at the Hilton Chicago.
The findings point to a new drug target for type 1 diabetes and other autoimmune diseases.
A new study shows that smoking may increase the risk of multiple sclerosis (MS) in people who also have specific established risk factors for MS.
The future of organ transplantation could include microscopic beads that create "designer" immune cells to help patients tolerate their new organ, Medical College of Georgia researchers say.
Recent genetic studies have revealed several new sites of genes that are risk factors for developing rheumatoid arthritis (RA). The strongest association with anti-citrullinated protein antibody (ACPA)-positive RA (ACPAs are autoantibodies detected in RA that are used as a major diagnostic tool) has been found for the HLA-DRB1 gene, and this site seems to play a central role in susceptibility to the disease in Caucasian populations.
Ten years ago, Stanford University School of Medicine scientist Emmanuel Mignot, MD, PhD, and his colleagues made headlines when they identified the culprit behind the sleep disorder narcolepsy.
Mutations that help HIV hide from the immune system undermine the virus's ability to replicate, show an international team of researchers in the April 13 issue of the Journal of Experimental Medicine.
Development of an AIDS vaccine is becoming an even greater challenge as scientists reported on Thursday that the human immunodeficiency virus (HIV) is evolving at a fast pace in order to bypass the human bodyâ€™s immune system.
EDMONTON, Sept. 4 /PRNewswire-FirstCall/ -- BioMS Medical Corp.
HLA-B*5701 biomarker indicates risk for severe adverse reactions to Abacavir / Experts expect more tests for similar markers in the future Venlo, The Netherlands - August 19, 2008 - QIAGEN (Nasdaq: QGEN; Frankfurt Prime Standard: QIA) today announced that it has introduced a new molecular diagnostic test to type the HLA-B*5701 allele, a genetic variation in the Human Leucocyte Antigen (HLA) system.